# Radiosurgery and Avastin for Recurrent Malignant Gliomas

> **NCT01017250** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 15 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **RADIATION:** Stereotactic Radiosurgery (SRS)
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT01017250
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-03
- **Final completion:** 2012-02
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01017250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01017250, "Radiosurgery and Avastin for Recurrent Malignant Gliomas". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT01017250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*